HolderBook

Y-MABS THERAPEUTICS INC (YMAB)

Institutional ownership reported to the SEC as of Q3 2025, across 28 quarters.

2
Reporting holders
$78.3K
Reported value
0.0%
Held as options
-91
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
Brooklyn Investment Group$75.5K16,0610.01%4q+224.4%+$52.2K
IFP Advisors, Inc$2.9K3320.00%4q-0.6%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 20252$78.3K16,3930110.0%
Q2 202593$125.3M27,756,1811425340.1%
Q1 202596$127.7M28,794,4631438250.1%
Q4 2024106$225.0M28,727,7781137280.0%
Q3 202497$337.3M25,603,2241533270.2%
Q2 202492$290.6M24,027,7151431320.1%
Q1 202489$369.0M22,613,0131822360.4%
Q4 202386$132.3M19,390,635831260.0%
Q3 202386$99.9M18,362,691426340.0%
Q2 202388$125.4M18,507,8161929260.0%
Q1 202373$85.9M17,163,3631125220.1%
Q4 202270$78.6M16,110,5651319240.1%
Q3 2022100$341.5M23,559,5511427310.5%
Q2 202294$377.3M24,763,5111432260.7%
Q1 202289$303.3M25,303,9031727320.9%
Q4 202195$418.6M25,825,9571238240.0%
Q3 202197$749.7M26,245,2031039300.1%
Q2 2021100$886.9M26,145,4471341210.0%
Q1 2021117$805.3M26,512,6171853270.1%
Q4 2020114$1.1B22,478,6511447340.0%
Q3 2020106$823.2M21,438,909939380.0%
Q2 2020109$928.4M21,490,0893341280.0%
Q1 202080$528.9M20,316,335929300.0%
Q4 201981$622.0M19,905,1872537100.0%
Q3 201965$347.0M13,317,3341128130.0%
Q2 201959$254.5M11,128,078202490.0%
Q1 201944$222.3M8,480,990612150.0%
Q4 201842$177.3M8,764,0652100.0%